Fish oil supplementation reduces the CERT2 risk score in adults with increased cardiometabolic risk: Findings from the MoKaRi trial.

Witoslawska A, Dawczynski C, Lääperi M, Hurme R, Kiehntopf M, Lorkowski S, März W, Laaksonen R, Moissl-Blanke AP

Open source

DOI
10.1016/j.jacl.2026.08.013
Published
2026 Sep 9
Container
Journal of clinical lipidology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jacl.2026.08.013,
  title = {Fish oil supplementation reduces the CERT2 risk score in adults with increased cardiometabolic risk: Findings from the MoKaRi trial.},
  author = {Witoslawska A and Dawczynski C and Lääperi M and Hurme R and Kiehntopf M and Lorkowski S and März W and Laaksonen R and Moissl-Blanke AP},
  year = {2026},
  journal = {Journal of clinical lipidology},
  doi = {10.1016/j.jacl.2026.08.013},
  url = {https://doi.org/10.1016/j.jacl.2026.08.013}
}

RIS

TY  - JOUR
TI  - Fish oil supplementation reduces the CERT2 risk score in adults with increased cardiometabolic risk: Findings from the MoKaRi trial.
AU  - Witoslawska A
AU  - Dawczynski C
AU  - Lääperi M
AU  - Hurme R
AU  - Kiehntopf M
AU  - Lorkowski S
AU  - März W
AU  - Laaksonen R
AU  - Moissl-Blanke AP
PY  - 2026
JO  - Journal of clinical lipidology
DO  - 10.1016/j.jacl.2026.08.013
UR  - https://doi.org/10.1016/j.jacl.2026.08.013
ER  - 

APA

A, W., C, D., M, L., R, H., M, K., S, L., W, M., R, L., & AP, M. (2026). Fish oil supplementation reduces the CERT2 risk score in adults with increased cardiometabolic risk: Findings from the MoKaRi trial.. Journal of clinical lipidology. https://doi.org/10.1016/j.jacl.2026.08.013

Source records